NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘biotech’

18 July 2016

May biotech PE, VC deal numbers boom falls back to earth $

dna-694798_1920 The number of biotech deals done by private equity and venture capital firms has dropped back sharply from May's 12-month high, new research shows.

9 June 2016

Biotech continues month-on-month rise in PE, VC investment $

research-1029340_1920 The value of private equity, venture capital and development capital targeting biotech companies increased for the third successive month in May to $498m, new research shows.

31 May 2016

5AM Ventures raises $285m for biggest-ever fund

sunrise-182302_1280 Biotech-focused 5AM Ventures has raised at least $285m for its fifth fund, less than three years after closing its formerly largest-ever fundraise on $250m.

25 May 2016

Albion sells biotech business Haemostatix

blood-75302_1280 Albion Ventures and other investors have sold their stakes in biotech business Haemostatix.

13 April 2016

Month-on-month uptick still leaves biotech PE, VC investment at relative low $

research-1029340_1920 Private equity and venture capital investment in biotech companies received a slight uptick in March, but still recorded one of its leanest results in the past 12 months, new research shows.

10 March 2016

PE, VC biotech investment hits new 12-month low $

flasks-606612_1920 Private equity and venture capital investment in the biotech sector hit a new 12-month low last month amid consecutives falls in both volume and total value.

23 October 2015

Israel Biotech targets $100m for debut fund

isr Newly formed venture capital firm Israel Biotech Fund has launched its first fund with a $100m target, AltAssets understands.

14 October 2015

Year-on-year PE, VC biotech investment jumps despite monthly slide $

tube-786932_1920 The value of private equity, venture capital and development capital investment targeting global biotechnology companies was up more than a third year-on-year in September despite a month-on-month drop.

18 August 2015

Warburg Pincus, Sutter Hill Ventures in $100m consumer-focused genome project

DNA, gene strand Warburg Pincus, the New York-based private equity firm, and Palo Alto, California's Sutter Hill Ventures are joining forces with US gene-sequencing giant Illumina to launch a new company they say will "empower consumers to discover insights into their own genomes".

17 August 2015

UK activity bolsters biotech investment from PE, VC firms $

dna-163466_1280 The value of private equity, venture capital and development capital investment in the global biotechnology sector increased for the second month in a row in July to reach its highest point of 2015 so far new research shows.

Page 1 of 1312345...10...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016